News
But while experts now know a fair amount about ancient Egyptian life, they still understand very little about the ...
A DNA bone test on a man who lived 4,500 years ago in the Nile Valley has shed new light on the rise of the Ancient Egyptian ...
For the very first time, scientists have sequenced DNA from the entire genome of an individual who lived in ancient Egypt up ...
CLEVELAND, Ohio — Minor league baseball has always been the laboratory for sports marketing creativity, but the Erie Sea ...
He propped up his cellphone next to his laptop and hit record on a video app. There were several people in the meeting with Sharon, who at the time was a pediatrician with the University of Minnesota ...
Walking through the devil’s mouth entrance (yes, literally a giant devil head with glowing yellow horns that you walk through) feels like crossing some bizarre threshold between the ordinary world and ...
A common refrain on the furniture beat is that couches are getting both worse and more expensive. If I had a dime for every ...
3d
Bounding Into Comics on MSNFrom ‘Chrono Trigger’ To ‘Sakura Wars’, Here’s 8 Japanese RPG Franchises That Desperately Need A RevivalJRPGs are still popular with western gamers but some of the best Japanese video game franchises that started the genre have ...
2d
Mongabay News on MSNFirst-ever assessment highlights threats to Atlantic cold-water coralsThey live in the ocean’s coldest, darkest depths, far from sight — but cold-water corals are far from safe. In a first-of-its ...
Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later.
Detailed results from the trial will be shared at a future medical meeting. Zai Lab holds the development and commercialization rights for bemarituzumab for mainland China, Hong Kong, Macau, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results